Here's Why Clovis Oncology Dropped As Much As 21.2% Today

Shares of Clovis Oncology (NASDAQ: CLVS) fell over 21% today after AstraZeneca (NYSE: AZN) and Merck (NYSE: MRK) reported promising data for olaparib as a treatment for BRCA-mutated ovarian cancer in patients who completed chemotherapy. The excitement is over a measure called progression-free survival (PFS), or how long a patient goes without seeing cancer worsen or reappear.In a study named SOLO-1, the median PFS for patients receiving placebo was 13.8 months.

Topics:  nasdaq   clvs    astrazeneca nyse   azn    merck nyse   mrk    brca-mutated   solo-1   clovis   oncology   pfs   today   months   olaparib   shares   receiving   median   cancer   placebo   patients   
BING NEWS:
  • Jude Bellingham ‘housery’ fails to unnerve Harry Kane in Bayern Munich-Real Madrid draw
    Having a bet on tonight’s match? First take a look at the offers on these best betting sites.
    04/30/2024 - 6:54 pm | View Link
  • Do cutting-edge CAR-T-cell therapies cause cancer? What the data say
    Regulators have identified around 30 cases of cancer linked to this blockbuster treatment. But is CAR T to blame? The hunt is on for answers.
    04/29/2024 - 1:00 pm | View Link
  • Trump trial live: Full jury seated in hush money case with first witness to testify as soon as Monday
    Trump appears to fall asleep in court as historic hush money trial gets underway in New York: Live - Jury selection got underway in New York in the former president’s first criminal case where he is c ...
    04/19/2024 - 2:15 am | View Link
  • Pfizer's Innovative Drug Pipeline Provides Ample Reason To Buy It Here
    COVID era, emphasizing innovation, oncology, and AI in drug development for potential growth. Learn more on PFE stock here.
    04/12/2024 - 8:30 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News